Características Clínico-patológicas del patrón de glomeruloesclerosis focal y segmentaria por biopsia renal en la región caribe colombiana entre los años 2010 y 2020
| datacite.rights | http://purl.org/coar/access_right/c_16ec | spa |
| dc.contributor.advisor | Aroca Martínez, Gustavo José | |
| dc.contributor.advisor | González Torres, Henry Joseth | |
| dc.contributor.author | Sepúlveda Ospino, Carlos José | |
| dc.date.accessioned | 2021-12-03T20:54:27Z | |
| dc.date.available | 2021-12-03T20:54:27Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | Introducción: Glomeruloesclerosis focal y segmentaria, también es llamada hialinosis focal y segmentaria, hace referencia a un patrón histológico, pero que indica un síndrome clínico patológico, siendo este una característica posiblemente de seis etiologías subyacentes distintas que como se ha venido mencionando lo característico que se va a observar es la cicatrización del glomérulo de forma progresiva, de tal forma que estas etiologías comparten un tema común de lesión y depleción de los podocitos, lo que se concluye no es una enfermedad única, sino un patrón morfológico de lesión que se desarrolla a partir de una amplia gama de etiologías. Objetivo: Describir las características Clínico-Patológicas del Patrón de glomeruloesclerosis Focal y Segmentaria por Biopsia Renal en una Clínica de Referencia en la Región Caribe Colombiana entre los años 2010 y 2020. | spa |
| dc.description.abstract | Background: Focal segmental glomerulosclerosis It is also called focal and segmental hyalinosis, it refers to a histological pattern, but indicates a clinical pathological syndrome, this being a characteristic possibly of six different underlying etiologies that, as has been mentioned, the characteristic that is going to be observed is the scarring of the glomerulus progressively, in such a way that these etiologies share a common theme of injury and depletion of podocytes, which is concluded is not a single disease, but a morphological pattern of injury that develops from a wide range of etiologies. Objective: To describe the Clinical-Pathological characteristics of the Focal and Segmental Glomerulosclerosis Pattern by Renal Biopsy in a Reference Clinic in the Colombian Caribbean Region between 2010 and 2020. | eng |
| dc.format.mimetype | spa | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12442/9196 | |
| dc.language.iso | spa | spa |
| dc.publisher | Ediciones Universidad Simón Bolívar | spa |
| dc.publisher | Facultad de Ciencias de la Salud | spa |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.accessrights | info:eu-repo/semantics/restrictedAccess | spa |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.subject | Glomeruloesclerosis focal y segmentaria | spa |
| dc.subject | Síndrome nefrótico | spa |
| dc.subject | Complemento | spa |
| dc.subject | Obesidad | spa |
| dc.subject | Proteinuria | spa |
| dc.subject | Focal and segmental glomerulosclerosis | eng |
| dc.subject | Nephrotic syndrome | eng |
| dc.subject | Complement | eng |
| dc.subject | Obesity | eng |
| dc.title | Características Clínico-patológicas del patrón de glomeruloesclerosis focal y segmentaria por biopsia renal en la región caribe colombiana entre los años 2010 y 2020 | spa |
| dc.type.driver | info:eu-repo/semantics/other | spa |
| dc.type.spa | Otros | spa |
| dcterms.references | Praga M, Cánovas JM, Sevillano AM, Martínez MA, Cavero T. Glomerulonefritis primarias. Med - Programa Form Médica Contin Acreditado. 2015 Jun;11(82):4893–901. | eng |
| dcterms.references | Stokes MB, Valeri AM, Markowitz GS, D’Agati VD. Cellular focal segmental glomerulosclerosis: Clinical and pathologic features. Kidney Int. 2006 Nov;70(10):1783–92. | eng |
| dcterms.references | García D, Jiménez H. Cambios estructurales renales en el riñón con el envejecimiento: con énfasis en glomeruloesclerosis. Med Leg Costa Rica. 2018;35(1):75–83. | spa |
| dcterms.references | Segarra-Medrano A, Jatem-Escalante E, Agraz-Pamplona I, Carnicer-Cáceres C, Ramos-Terrades N, Ostos-Roldán E, et al. Tratamiento de la glomeruloesclerosis focal y segmentaria idiopática: Opciones en caso de resistencia a corticosteroides y anticalcineurínicos. Nefrologia. 2013;33(4):448–61. | spa |
| dcterms.references | Jerzak P, Konieczny A, Sroka M, Lis Ł, Podgórski P, Witkiewicz W, et al. Focal and segmental glomerulosclerosis in adults: Early clinical course and prognostic factors for short-term outcome. Rev Nefrol Dial y Traspl. 2021; | eng |
| dcterms.references | Conde Olasagasti JL, Acevedo Ribó M, Roca Muñoz A, Vozmediano Poyatos C, Rivera F, Illescas Fernández-Bermejo ML, et al. Estudio evolutivo de las glomerulonefritis en Castilla-La Mancha (GLOMANCHA) en el periodo 1994-2008. Nefrologia. 2016;36(3):237–42. | spa |
| dcterms.references | Vega SJ, Esquinas P, Flórez A, Torres MM, Andrade R. Alteraciones genéticas del Gen α-Actina 4 y de ultraestructura en Glomeruloesclerosis Focal y Segmentaria idiopática y Nefropatía por IgA. 2013; | spa |
| dcterms.references | Karakurt N, Oguz EG, Yayar O, Sahin H, Aylı MD. RETROSPECTIVE ANALYSIS OF CLINICAL DATA AND TREATMENT OF PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS PATIENTS. Rev Nefrol Dial y Traspl. 2019; | eng |
| dcterms.references | Serna F, Torres J, Diana S. Enfermedades renales diagnosticadas por biopsia: descripción clínica, histológica y epidemiológica. Resultados de la población atendida entre 1992 y 2010 en el servicio de nefrología del Hospital Universitario san Juan de Dios. Armenia (Colombia). Rev Médicas Uis. 2011; | spa |
| dcterms.references | Rabasco C, Martínez A, Ortega R, Espinosa M. Glomeruloesclerosis focal y segmentaria primaria con mutación en el gen NPHS2. Correlación clínico-patológica. Soc Española Nefrol. 2020; | spa |
| dcterms.references | Coronado C, Echeverry I. Descripción clinicopatológica de las enfermedades glomerulares. Acta Medica Colomb. 2016;41. | spa |
| dcterms.references | Sanchez M. GENES IMPLICADOS EN LA GLOMERULOESCLEROSIS FOCAL Y SEGMENTARIA AUTOSÓMICA DOMINANTE. Universidad de Santiago de Compostela; 2011. | spa |
| dcterms.references | Wiggins RC, Alpers CE, Holzman LB, He JC, Salant DJ, Chugh SS, et al. Glomerular Disease: Looking beyond Pathology. Clin J Am Soc Nephrol. 2014 Jun;9(6):1138–40. | eng |
| dcterms.references | Orr P, Shank BC, Hickson S, Cooke J. Clinical Management of Glomerular Diseases. Nurs Clin North Am. 2018 Dec;53(4):551–67. | eng |
| dcterms.references | Bueno G, Fernandez-Carrobles MM, Gonzalez-Lopez L, Deniz O. Glomerulosclerosis identification in whole slide images using semantic segmentation. Comput Methods Programs Biomed. 2020 Feb;184(2020):105273. | eng |
| dcterms.references | Barrera-Herrera LE, López Panqueva R del P, Flórez Vargas AA, Andrade Pérez RE. The spectrum of glomerular disease between the years 2003 and 2015 in Columbia: A review of 12,613 cases. Rev Española Patol. 2017 Jan;50(1):3–7. | eng |
| dcterms.references | Sethi S, Haas M, Markowitz GS, D’Agati VD, Rennke HG, Jennette JC, et al. Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN. J Am Soc Nephrol. 2016 May;27(5):1278–87. | eng |
| dcterms.references | Wenderfer SE, Gaut JP. Glomerular Diseases in Children. Adv Chronic Kidney Dis. 2017 Nov;24(6):364–71. | eng |
| dcterms.references | Vázquez Martul E. Orientación diagnóstica de las enfermedades renales glomerulares. Rev Española Patol. 2013 Jan;46(1):3–13. | spa |
| dcterms.references | Coronado C, Echeverry I. Descripción clinicopatológica de las enfermedades glomerulares. Acta Medica Colomb. 2016;41(2):125–9. | spa |
| dcterms.references | Valencia VC, Orizaga C, Cruz D La, Guillermo J, Fuentes B, Ramírez FF, et al. Epidemiología de la enfermedad glomerular en adultos. Revisión de una base de datos. Gac Med Mex. 2014;150:403–8. | spa |
| dcterms.references | Egido J, Alcázar Arroyo R, Ortiz A. Glomerulonefritis: concepto y clasificación. Etiopatogenia de las glomerulonefritis. Med - Programa Form Médica Contin Acreditado. 2011 Jun;10(82):5525–31. | spa |
| dcterms.references | Dussol B. Nefropatías glomerulares: orientación diagnóstica y evolución. EMC - Tratado Med. 2015 Dec;19(4):1–11. | spa |
| dcterms.references | Hogan J, Mohan P, Appel GB. Diagnostic Tests and Treatment Options in Glomerular Disease: 2014 Update. Am J Kidney Dis. 2014 Apr;63(4):656–66. | eng |
| dcterms.references | Salvi M, Mogetta A, Gambella A, Molinaro L, Barreca A, Papotti M, et al. Automated assessment of glomerulosclerosis and tubular atrophy using deep learning. Comput Med Imaging Graph. 2021 Jun;90(May):101930. | eng |
| dcterms.references | Jefferson JA, Shankland SJ. The Pathogenesis of Focal Segmental Glomerulosclerosis. Adv Chronic Kidney Dis. 2014 Sep;21(5):408–16. | eng |
| dcterms.references | Jefferson JA, Nast CC. Focal and Segmental Glomerulosclerosis—Are We There Yet? Adv Chronic Kidney Dis. 2014 Sep;21(5):398–9. | eng |
| dcterms.references | Zhong Y, Xu F, Li X, Chen H, Liang S, Zhu X, et al. The evolution of morphological variants of focal segmental glomerulosclerosis: a repeat biopsy-based observation. Nephrol Dial Transplant. 2016 Jan;31(1):87–95. | eng |
| dcterms.references | McGrogan A, Franssen CFM, de Vries CS. The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. Nephrol Dial Transplant. 2011 Feb;26(2):414–30. | eng |
| dcterms.references | D’Agati VD, Kaskel FJ, Falk RJ. Focal Segmental Glomerulosclerosis. N Engl J Med. 2011 Dec;365(25):2398–411. | eng |
| dcterms.references | Sim JJ, Batech M, Hever A, Harrison TN, Avelar T, Kanter MH, et al. Distribution of Biopsy-Proven Presumed Primary Glomerulonephropathies in 2000-2011 Among a Racially and Ethnically Diverse US Population. Am J Kidney Dis. 2016 Oct;68(4):533–44. | eng |
| dcterms.references | Sethi S, Glassock RJ, Fervenza FC. Focal segmental glomerulosclerosis: towards a better understanding for the practicing nephrologist. Nephrol Dial Transplant. 2015 Mar;30(3):375–84. | eng |
| dcterms.references | Rosenberg AZ, Kopp JB. Focal Segmental Glomerulosclerosis. Clin J Am Soc Nephrol. 2017 Mar;12(3):502–17. | eng |
| dcterms.references | Gallon L, Leventhal J, Skaro A, Kanwar Y, Alvarado A. Resolution of Recurrent Focal Segmental Glomerulosclerosis after Retransplantation. N Engl J Med. 2012 Apr;366(17):1648–9. | eng |
| dcterms.references | Savin VJ, Sharma M, Zhou J, Gennochi D, Fields T, Sharma R, et al. Renal and Hematological Effects of CLCF-1, a B-Cell-Stimulating Cytokine of the IL-6 Family. J Immunol Res. 2015;2015:1–11. | eng |
| dcterms.references | Lopez-Hellin J, Cantarell C, Jimeno L, Sanchez-Fructuoso A, Puig-Gay N, Guirado L, et al. A Form of Apolipoprotein A-I Is Found Specifically in Relapses of Focal Segmental Glomerulosclerosis Following Transplantation. Am J Transplant. 2013 Feb;13(2):493–500. | eng |
| dcterms.references | Delville M, Sigdel TK, Wei C, Li J, Hsieh S-C, Fornoni A, et al. A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation. Sci Transl Med. 2014 Oct;6(256):256ra136-256ra136. | eng |
| dcterms.references | Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med. 2011 Aug;17(8):952–60. | eng |
| dcterms.references | Kriz W, Lemley K V. Mechanical challenges to the glomerular filtration barrier: adaptations and pathway to sclerosis. Pediatr Nephrol. 2017 Mar;32(3):405–17. | eng |
| dcterms.references | Ikezumi Y, Suzuki T, Karasawa T, Yamada T, Hasegawa H, Nishimura H, et al. Low Birthweight and Premature Birth Are Risk Factors for Podocytopenia and Focal Segmental Glomerulosclerosis. Am J Nephrol. 2013;38(2):149–57. | eng |
| dcterms.references | Morgan C, Al-Aklabi M, Guerra GG. Chronic Kidney Disease in Congenital Heart Disease Patients: A Narrative Review of Evidence. Can J Kidney Heal Dis. 2015 Jan;2(1):63. | eng |
| dcterms.references | Aygun B, Mortier NA, Smeltzer MP, Hankins JS, Ware RE. Glomerular hyperfiltration and albuminuria in children with sickle cell anemia. Pediatr Nephrol. 2011 Aug;26(8):1285–90. | eng |
| dcterms.references | Wickman C, Kramer H. Obesity and Kidney Disease: Potential Mechanisms. Semin Nephrol. 2013 Jan;33(1):14–22. | eng |
| dcterms.references | Herlitz LC, Markowitz GS, Farris AB, Schwimmer JA, Stokes MB, Kunis C, et al. Development of Focal Segmental Glomerulosclerosis after Anabolic Steroid Abuse. J Am Soc Nephrol. 2010 Jan;21(1):163–72. | eng |
| dcterms.references | Hanly PJ, Ahmed SB. Sleep Apnea and the Kidney. Chest. 2014 Oct;146(4):1114–22. | eng |
| dcterms.references | Gasser DL, Winkler CA, Peng M, An P, McKenzie LM, Kirk GD, et al. Focal segmental glomerulosclerosis is associated with a PDSS2 haplotype and, independently, with a decreased content of coenzyme Q 10. Am J Physiol Physiol. 2013 Oct;305(8):F1228–38. | eng |
| dcterms.references | Gast C, Pengelly RJ, Lyon M, Bunyan DJ, Seaby EG, Graham N, et al. Collagen ( COL4A ) mutations are the most frequent mutations underlying adult focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2016 Jun;31(6):961–70. | eng |
| dcterms.references | Chandra P, Kopp JB. Viruses and collapsing glomerulopathy: a brief critical review: Table 1. Clin Kidney J. 2013 Feb;6(1):1–5. | eng |
| dcterms.references | Meehan SM, Kim L, Chang A. A spectrum of morphologic lesions of focal segmental glomerulosclerosis by Columbia criteria in human immunodeficiency virus infection. Virchows Arch. 2012 Apr;460(4):429–35. | eng |
| dcterms.references | Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P, et al. APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy. J Am Soc Nephrol. 2011 Nov;22(11):2129–37. | eng |
| dcterms.references | Kasembeli AN, Duarte R, Ramsay M, Mosiane P, Dickens C, Dix-Peek T, et al. APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans. J Am Soc Nephrol. 2015 Nov;26(11):2882–90. | eng |
| dcterms.references | Mohamed N, Goldstein J, Schiff J, John R. Collapsing Glomerulopathy Following Anthracycline Therapy. Am J Kidney Dis. 2013 May;61(5):778–81. | eng |
| dcterms.references | Stokes MB, D’Agati VD. Morphologic Variants of Focal Segmental Glomerulosclerosis and Their Significance. Adv Chronic Kidney Dis. 2014 Sep;21(5):400–7. | eng |
| dcterms.references | Sangameswaran KDG, Baradhi KM. Focal Segmental Glomerulosclerosis. Statpearls …. 2020. | eng |
| dcterms.references | Han M-H, Kim Y-J. Practical Application of Columbia Classification for Focal Segmental Glomerulosclerosis. Biomed Res Int. 2016;2016(MCD):1–7. | eng |
| dcterms.references | González L, Cantillo J. Abordaje diagnóstico de la enfermedad glomerular del adulto. Acta Med Colomb. 2013;38:101–7. | eng |
| dcterms.references | Segarra A. Glomerulosclerosis Focal y Segmentaria. Nefrol al dia. 2018; | eng |
| dcterms.references | Egido J, Rojas-Rivera J, Barat A. Glomerulonefritis crónicas. Med - Programa Form Médica Contin Acreditado. 2011 Jun;10(82):5542–59. | eng |
| dcterms.references | Jellouli M, Abidi K, Askri M, Ferjani M, Naija O, Hammi Y, et al. Focal segmental glomerulosclerosis in children. Tunis Med. 2016;94(5). | eng |
| dcterms.references | Niznik RS, Lopez CL, Kremers WK, Denic A, Sethi S, Stegall MD, et al. Global Glomerulosclerosis in Kidney Biopsies With Differing Amounts of Cortex: A Clinical-Pathologic Correlation Study. Kidney Med. 2019 Jul;1(4):153–61. | eng |
| dcterms.references | Brown EJ, Pollak MR, Barua M. Genetic testing for nephrotic syndrome and FSGS in the era of next-generation sequencing. Kidney Int. 2014 May;85(5):1030–8. | eng |
| dcterms.references | Rovin BH, Caster DJ, Cattran DC, Gibson KL, Hogan JJ, Moeller MJ, et al. Manejo y tratamiento de enfermedades glomerulares (Parte 2): Conclusiones KDIGO. Kidney Int. 2019;95(2):281–95. | spa |
| dcterms.references | Mallipattu SK, He JC. The podocyte as a direct target for treatment of glomerular disease? Am J Physiol Physiol. 2016 Jul;311(1):F46–51. | eng |
| dcterms.references | Laurin L-P, Gasim AM, Poulton CJ, Hogan SL, Jennette JC, Falk RJ, et al. Treatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGS. Clin J Am Soc Nephrol. 2016 Mar;11(3):386–94. | eng |
| dcterms.references | Canaud G, Zuber J, Sberro R, Royale V, Anglicheau D, Snanoudj R, et al. Intensive and Prolonged Treatment of Focal and Segmental Glomerulosclerosis Recurrence in Adult Kidney Transplant Recipients: A Pilot Study. Am J Transplant. 2009 May;9(5):1081–6. | eng |
| dcterms.references | Büscher AK, Beck BB, Melk A, Hoefele J, Kranz B, Bamborschke D, et al. Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid–Resistant Nephrotic Syndrome. Clin J Am Soc Nephrol. 2016 Feb;11(2):245–53. | eng |
| dcterms.references | El-Refaey AM, Bakr A, Hammad A, Elmougy A, El-Houseeny F, Abdelrahman A, et al. Primary focal segmental glomerulosclerosis in Egyptian children: a 10-year single-centre experience. Pediatr Nephrol. 2010 Jul;25(7):1369–73. | eng |
| dcterms.references | Mubarak M, Kazi J, Shakeel S. Frequency and clinicopathological correlations of histopathological variants of pediatric idiopathic focal segmental glomerulosclerosis. Indian J Nephrol. 2014;24(3):148. | eng |
| dcterms.references | Kwon YE, Han SH, Kie JH, An SY, Kim YL, Park KS, et al. Clinical features and outcomes of focal segmental glomerulosclerosis pathologic variants in Korean adult patients. BMC Nephrol. 2014 Dec;15(1):52. | eng |
| dcterms.references | Greenwood AM, Gunnarsson R, Neuen BL, Oliver K, Green SJ, Baer RA. Clinical presentation, treatment and outcome of focal segmental glomerulosclerosis in Far North Queensland Australian adults. Nephrology. 2017 Jul;22(7):520–30. | eng |
| dcterms.references | Tsuchimoto A, Matsukuma Y, Ueki K, Tanaka S, Masutani K, Nakagawa K, et al. Utility of Columbia classification in focal segmental glomerulosclerosis: renal prognosis and treatment response among the pathological variants. Nephrol Dial Transplant. 2020 Jul;35(7):1219–27. | eng |
| dcterms.references | Rosenberg AZ, Kopp JB. Focal segmental glomerulosclerosis. Clin J Am Soc Nephrol. 2017;12(3):502–17. | eng |
| dcterms.references | Roja JR, Pérez M, Hurtado A, Asato C. [Factors predicting for renal survival in primary focal segmental glomerulosclerosis]. Nefrologia [Internet]. 2008;28(4):439–46. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18662153 | eng |
| dcterms.references | Tanoue A, Katayama K, Ito Y, Joh K, Toda M, Yasuma T, et al. Podocyte-specific Crb2 knockout mice develop focal segmental glomerulosclerosis. Sci Rep [Internet]. 2021 Dec 15;11(1):20556. Available from: https://www.nature.com/articles/s41598-021-00159-z | eng |
| dcterms.references | Castillo Parodi L, Navarro Jiménez E, Arango Quiroz Y, López Avendaño A, Mejía Varela V, González Torres HJ, et al. Obesity Association with Chronic Renal Disease in Patients attended at Clínica de la Costa. Barranquilla, Colombia. 2005-2014. Rev Colomb Nefrol [Internet]. 2016 Jan 1;3(1):14–9. Available from: http://www.revistanefrologia.org/index.php/rcn/article/view/217/pdf | eng |
| dcterms.references | Ismail MI, Lakouz K, Abdelbary E. Clinicopathological correlations of renal pathology: A single center experience. Saudi J Kidney Dis Transpl [Internet]. 2016 May;27(3):557–62. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27215250 | eng |
| dcterms.references | Roca N, Madrid A, Lopez M, Fraga G, Jatem E, Gonzalez J, et al. Multidimensional inflammatory and immunological endotypes of idiopathic focal segmental glomerulosclerosis and their association with treatment outcomes. Clin Kidney J [Internet]. 2021 Jul;14(7):1826–34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/34221390 | eng |
| oaire.version | info:eu-repo/semantics/acceptedVersion | spa |
| sb.programa | Especialización en Medicina Interna | spa |
| sb.sede | Sede Barranquilla | spa |